Nyxoah (Nyxoah) Additional Paid-In Capital : $267.60 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Nyxoah Additional Paid-In Capital?

Nyxoah's quarterly additional paid-in capital increased from Sep. 2023 ($262.68 Mil) to Dec. 2023 ($268.41 Mil) but then stayed the same from Dec. 2023 ($268.41 Mil) to Mar. 2024 ($267.60 Mil).

Nyxoah's annual additional paid-in capital declined from Dec. 2021 ($257.66 Mil) to Dec. 2022 ($241.82 Mil) but then increased from Dec. 2022 ($241.82 Mil) to Dec. 2023 ($268.41 Mil).

Nyxoah Additional Paid-In Capital Historical Data

The historical data trend for Nyxoah's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Additional Paid-In Capital Chart

Nyxoah Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

52.96

183.62

257.66

241.82

268.41

Nyxoah Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															260.69	266.60	262.68	268.41	267.60

Nyxoah Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Nyxoah Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Nyxoah's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyxoah (Nyxoah) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (NAS:NYXH) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

5YI:Germany NYXH:Belgium

Address

Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435

Website

https://www.nyxoah.com

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.